1,136 results on '"Singer, Eric A."'
Search Results
2. Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043
3. Integration of Palliative Care into the Renal Cancer Treatment Paradigm
4. Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
5. Special populations in metastatic renal cell carcinoma
6. Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
7. Impact of Dobbs v. Jackson Women’s Health Organization on Professional Decision-Making Among Urology Applicants
8. Editorial Comment
9. Informed consent and trainee participation in urologic surgery
10. The Role of Immunotherapy in Renal Cell Carcinoma
11. Integrating Surgery in the Multidisciplinary Care of Advanced Renal Cell Carcinoma
12. The Promise of Neoadjuvant and Adjuvant Therapies for Renal Cancer
13. PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex
14. Peri-Operative DNR: An Ethical Dilemma
15. Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative
16. Active Surveillance in Metastatic Renal Cell Carcinoma
17. PD23-08 RETHINKING THE DEFINITION OF STAGE III IN ADRENOCORTICAL CARCINOMA: ASSESSING THE IMPACT OF CLINICAL LYMPH NODE POSITIVE DISEASE
18. Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability
19. Adversarial Domain Adaptation for Classification of Prostate Histopathology Whole-Slide Images
20. Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer.
21. Non-infectious complications following transrectal prostate needle biopsy – Outcomes from over 8000 procedures
22. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
23. Two is company, is three a crowd? Triplet therapy, novel molecular targets, and updates on the management of advanced renal cell carcinoma
24. Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
25. Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations
26. Inherited Germline Variants in Urinary Tract Cancer: A Multicenter Whole-Exome Sequencing Analysis and Correlation With Clinical Features and Tumor Genomics.
27. Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancer
28. Adjuvant Therapy for Renal Cell Carcinoma: End Points, Outcomes, and Risk Assessments
29. CHATGPT USE IN PATIENT AND TRAINEE EDUCATION FOR RENAL MASSES AND RENAL CELL CARCINOMA
30. Supplementary Table 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
31. FIGURE 2 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
32. Supplementary Table 5 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
33. Supplementary Table 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
34. Supplementary Figure 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
35. FIGURE 1 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
36. Supplementary Table 6 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
37. Supplementary Table 4 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
38. Supplementary Table 2 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
39. Data from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
40. FIGURE 3 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
41. Supplementary Table 7 from A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN Dataset
42. “Published abstracts from the 24th Annual Meeting of the Society of Urologic Oncology”
43. A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset
44. Sex-based differences in the transcriptomic metabolic profiling in young onset colorectal cancer (YOCRC).
45. Comparing the rate of immunotherapy treatment change due to toxicity by sex
46. Editorial Comment
47. Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
48. Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience
49. Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
50. Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.